期刊论文详细信息
Particle and Fibre Toxicology
Co-infection of tuberculosis and parasitic diseases in humans: a systematic review
Xiao-Nong Zhou1  Xin-Xu Li2 
[1] National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory of Parasite and Vector Biology, Ministry of Health, WHO Collaborating Centre for Malaria, Schistosomiasis and Filariasis, Shanghai, 200025, P. R. China;National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, P. R. China
关键词: Co-infection;    Parasitic diseases;    Tuberculosis;   
Others  :  1228023
DOI  :  10.1186/1756-3305-6-79
 received in 2013-01-04, accepted in 2013-03-18,  发布年份 2013
PDF
【 摘 要 】

Co-infection of tuberculosis and parasitic diseases in humans is an important public problem in co-endemic areas in developing countries. However, there is a paucity of studies on co-infection and even fewer reviews. This review examines 44 appropriate papers by PRISMA from 289 papers searched in PubMed via the NCBI Entrez system (no grey literature) up to December 2012 in order to analyze the factors that influence epidemic and host’s immunity of co-infection. The limited evidence in this review indicates that most common parasite species are concurrent with Mycobacterium tuberculosis in multiple organs; socio-demographics such as gender and age, special populations with susceptibility such as renal transplant recipients, patients on maintenance haemodialysis, HIV positive patients and migrants, and living in or coming from co-endemic areas are all likely to have an impact on co-infection. Pulmonary tuberculosis and parasitic diseases were shown to be risk factors for each other. Co-infection may significantly inhibit the host’s immune system, increase antibacterial therapy intolerance and be detrimental to the prognosis of the disease; in addition, infection with parasitic diseases can alter the protective immune response to Bacillus Calmette-Guerin vaccination against Mycobacterium tuberculosis.

【 授权许可】

   
2013 Li and Zhou; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150930085636959.pdf 309KB PDF download
Figure 1. 46KB Image download
【 图 表 】

Figure 1.

【 参考文献 】
  • [1]UNDP, World Bank: WHO Special Programme for Research and Training in Tropical Diseases (TDR): Tropical Disease Research: Progress 1999–2000 . Geneva, Switzerland: World Health Organization Press; 2001. WHO/TDR/GEN/01.5
  • [2]World Health Organization: Global tuberculosis control: WHO report 2011. Geneva, Switzerland: World Health Organization Press; 2011. WHO/HTM/TB/2011.16
  • [3]World Health Organization: World malaria report: 2010. Geneva, Switzerland: World Health Organization Press; 2010.
  • [4]World Health Organization: Schistosomiasis: progress report 2001–2011, strategic plan 2012–2020. Geneva, Switzerland: World Health Organization Press; 2013.
  • [5]World Health Organization: Progress report 2000–2009 and strategic plan 2010–2020 of the global programme to eliminate lymphatic filariasis: halfway towards eliminating lymphatic filariasis. Geneva, Switzerland: World Health Organization Press; 2010. WHO/HTM/NTD/PCT/2010.6
  • [6]Chatterjee Bahadur GC: How to treat pulmonary tuberculosis case running concurrently with malaria. Indian Med Rec 1945, 65:260-263.
  • [7]Black TC: Coexistent hookworm and tuberculosis. South Med J 1946, 39:881-884.
  • [8]Peces R, de la Torre M, Alcazar R: Visceral leishmaniasis and renal tuberculosis in a patient on maintenance haemodialysis. Nephrol Dial Transplant 1996, 11:707-708.
  • [9]Toledo AC Jr, de Castro MR: Pneumocystis carinii pneumonia, pulmonary tuberculosis and visceral leishmaniasis in an adult HIV negative patient. Braz J Infect Dis 2001, 5:154-157.
  • [10]Ersoy A, Gullulu M, Usta M, Ozcelik T, Ylmaz E, Uzaslan EK, Vuruskan H, Yavuz M, Oktay B, Dilek K, Yurtkuran M: A renal transplant recipient with pulmonary tuberculosis and visceral leishmaniasis: review of superimposed infections and therapy approaches. Clin Nephrol 2003, 60:289-294.
  • [11]Pandey K, Sinha PK, Ravidas VN, Kumar N, Verma N, Lal CS, Bimal S, Sur D, Bhattacharya SK: Nexus of infection with human immunodeficiency virus, pulmonary tuberculosis and visceral leishmaniasis: a case report from Bihar, India. Am J Trop Med Hyg 2005, 72:30-32.
  • [12]Das VN, Pandey K, Kumar N, Hassan SM, Bimal S, Lal CS, Siddiqui NA, Bhattacharya SK: Visceral leishmaniasis and tuberculosis in patients with HIV co-infection. Southeast Asian J Trop Med Public Health 2006, 37:18-21.
  • [13]Escobar MA, Saravia NG, Weigle KA: Concurrent mucosal leishmaniasis and pulmonary tuberculosis. Clin Infect Dis 1996, 23:836-837.
  • [14]Delobel P, Launois P, Djossou F, Sainte-Marie D, Pradinaud R: American cutaneous leishmaniasis, lepromatous leprosy, and pulmonary tuberculosis coinfection with downregulation of the T-helper 1 cell response. Clin Infect Dis 2003, 37:628-633.
  • [15]Rathnayake D, Ranawake RR, Sirimanna G, Siriwardhane Y, Karunaweera N, De Silva R: Co-infection of mucosal leishmaniasis and extra pulmonary tuberculosis in a patient with inherent immune deficiency. Int J Dermatol 2010, 49:549-551.
  • [16]Das VN, Pandey K, Verma N, Bimal S, Lal CS, Singh D, Das P: Post-kala-azar dermal leishmaniasis (PKDL), HIV and pulmonary tuberculosis. Natl Med J India 2010, 23:88-89.
  • [17]Duboucher C, Farto-Bensasson F, Cheron M, Peltier JY, Beaufils F, Perie G: Lymph node infection by Trichomonas tenax: report of a case with co-infection by Mycobacterium tuberculosis. Hum Pathol 2000, 31:1317-1321.
  • [18]Thapa R, Mallick D, Biswas B: Perinatal malaria and tuberculosis co-infection: a case report. Int J Infect Dis 2010, 14:e254-e256.
  • [19]Schroeder HW Jr, Yarrish RL, Perkins TF, Lee C: Sequential disseminated tuberculosis and toxoplasmosis in a Haitian refugee. South Med J 1984, 77:533-534.
  • [20]Guneratne R, Mendis D, Bandara T, Fernando SD: Toxoplasma, toxocara and tuberculosis co-infection in a four year old child. BMC Pediatr 2011, 11:44. BioMed Central Full Text
  • [21]Hwang EH, Ahn PG, Lee DM, Kim HS: Cerebral toxoplasmosis combined with disseminated tuberculosis. Journal of Korean Neurosurgical Society 2012, 51:316-319.
  • [22]Torresi J, Sievert W: Hepatosplenic schistosomiasis presenting as granulomatous hepatitis in an immigrant from the Philippines with pulmonary tuberculosis, tuberculous lymphadenitis, and a history of alcohol abuse. J Travel Med 2001, 8:216-218.
  • [23]Karande SC, Sheth SS, Lahiri KR, Shah MD: Coexistent hydatid disease and pulmonary tuberculosis in a five year old girl. J Assoc Physicians India 1991, 39:353-354.
  • [24]Zamani A, Aydemir Y, Gormus N, Odev K, Solak H: Cardiac hydatid cyst in a patient with pulmonary tuberculosis. Int J Tuberc Lung Dis 2002, 6:1033-1034.
  • [25]Chen SY, Du XL, Yan W: A case of liver multiple hydatidosis complicated by tuberculosis in liver and abdominal cavity. Zhonghua Gan Zang Bing Za Zhi 2004, 12:359.
  • [26]Saeed MY, Ahmed AH, Elhassan NB, Elhassan AM: Concomitant tuberculosis and hydatid cyst in a solitary pulmonary nodule of left lower lobe. BMJ Case Rep 2009, 2009:bcr04.2009.1738.
  • [27]Yang YR, Gray DJ, Ellis MK, Yang SK, Craig PS, McManus DP: Human cases of simultaneous echinococcosis and tuberculosis - significance and extent in China. Parasit Vectors 2009, 2:53. BioMed Central Full Text
  • [28]Dwarakanath AD, Welton M, Ellis CJ, Allan RN: Interrelation of strongyloidiasis and tuberculosis. Gut 1994, 35:1001-1003.
  • [29]Kumar MV, Kaviarasan PK, Thappa DM, Jaisankar JJ: Tuberculosis verrucosa cutis complicating tropical elephantiasis. Indian J Dermatol Venereol Leprol 2001, 67:49-51.
  • [30]Choi WY, Yoo JE, Kim WG, Yun BH, Kim SG, Yoo WH: Prevalence of intestinal helminthic infections and skin tests for paragonimus and clonorchis in tuberculosis patients. Kisaengchunghak Chapchi 1984, 22:209-214.
  • [31]El-Safi SH, Hamid N, Omer A, Abdel-Haleem A, Hammad A, Kareem HG, Boelaert M: Infection rates with Leishmania donovani and Mycobacterium tuberculosis in a village in eastern Sudan. Trop Med Int Health 2004, 9:1305-1311.
  • [32]Manuel Ramos J, Reyes F, Tesfamariam A: Intestinal parasites in adults admitted to a rural Ethiopian hospital: Relationship to tuberculosis and malaria. Scand J Infect Dis 2006, 38:460-462.
  • [33]Range N, Magnussen P, Mugomela A, Malenganisho W, Changalucha J, Temu MM, Mngara J, Krarup H, Friis H, Andersen AB: HIV and parasitic co-infections in tuberculosis patients: a cross-sectional study in Mwanza, Tanzania. Ann Trop Med Parasitol 2007, 101:343-351.
  • [34]Abate E, Belayneh M, Gelaw A, Idh J, Getachew A, Alemu S, Diro E, Fikre N, Britton S, Elias D: The impact of asymptomatic helminth co-infection in patients with newly diagnosed tuberculosis in north-west Ethiopia. PLoS One 2012, 7:e42901.
  • [35]Enwere GC, Ota MO, Obaro SK: The host response in malaria and depression of defence against tuberculosis. Ann Trop Med Parasitol 1999, 93:669-678.
  • [36]Scott CP, Kumar N, Bishai WR, Manabe YC: Short report: modulation of Mycobacterium tuberculosis infection by Plasmodium in the murine model. Am J Trop Med Hyg 2004, 70:144-148.
  • [37]Wiwanitkit V: Co-infection between tuberculosis and malaria: A consideration on interaction of molecules and pathogenesis. J Vector Borne Dis 2006, 43:195-197.
  • [38]Mueller AK, Behrends J, Hagens K, Mahlo J, Schaible UE, Schneider BE: Natural transmission of Plasmodium berghei exacerbates chronic tuberculosis in an experimental co-infection model. PLoS One 2012, 7:e48110.
  • [39]Vasil’ev AV, Shenderova RI, Ginzburg ZI, Vasil’ev VI: Tuberculosis of the lungs complicated by opisthorchiasis under conditions of the extreme north. Probl Tuberk 1989, 6:41-44.
  • [40]Kashuba EA, Rusakova LI: Anthelmintic therapy of opisthorchiasis in patients with active tuberculosis. Probl Tuberk 1992, 3-4:33-36.
  • [41]Kalenova LF, Zolotukhin VA, Kashuba EA, Kostina GI, Postnikova TF: The formation of host-parasite relationships in an experimental mixed pathology of opisthorchiasis-tuberculosis as dependent on the phase of the Opisthorchis infestation. Zh Mikrobiol Epidemiol Immunobiol 1992, 4:20-22.
  • [42]Kashuba EA, Podkletnova LF, Stepanova TF, Chebysheva EV: Functioning of opisthorchiasis-tuberculosis parasitocenosis at different stages of invasion (experimental investigation). Zh Mikrobiol Epidemiol Immunobiol 2003, 1:17-23.
  • [43]Hubner MP, Killoran KE, Rajnik M, Wilson S, Yim KC, Torrero MN, Morris CP, Nikonenko B, Blanco JC, Hemming VG, Mitre E: Chronic helminth infection does not exacerbate Mycobacterium tuberculosis infection. PLoS Negl Trop Dis 2012, 6:e1970.
  • [44]Metenou S, Babu S, Nutman TB: Impact of filarial infections on coincident intracellular pathogens: Mycobacterium tuberculosis and Plasmodium falciparum. Curr Opin HIV AIDS 2012, 7:231-238.
  • [45]Elias D, Britton S, Kassu A, Akuffo H: Chronic helminth infections may negatively influence immunity against tuberculosis and other diseases of public health importance. Expert Rev Anti Infect Ther 2007, 5:475-484.
  • [46]Resende Co T, Hirsch CS, Toossi Z, Dietze R, Ribeiro-Rodrigues R: Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy. Clin Exp Immunol 2007, 147:45-52.
  • [47]Mendez-Samperio P: Immunological mechanisms by which concomitant helminth infections predispose to the development of human tuberculosis. Korean J Parasitol 2012, 50:281-286.
  • [48]Rafi W, Ribeiro-Rodrigues R, Ellner JJ, Salgame P: Coinfection-helminthes and tuberculosis. Curr Opin HIV AIDS 2012, 7:239-244.
  • [49]Ferreira AP, Aguiar AS, Fava MW, Correa JO, Teixeira FM, Teixeira HC: Can the efficacy of bacille calmette-guerin tuberculosis vaccine be affected by intestinal parasitic infections? J Infect D 2002, 186:441-442. author reply 442–443
  • [50]Elias D, Akuffo H, Pawlowski A, Haile M, Schon T, Britton S: Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis. Vaccine 2005, 23:1326-1334.
  • [51]Parra M, Derrick SC, Yang A, Tian J, Kolibab K, Oakley M, Perera LP, Jacobs WR, Kumar S, Morris SL: Malaria infections do not compromise vaccine-induced immunity against tuberculosis in mice. PLoS One 2011, 6:e28164.
  • [52]Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009, 6:e1000100.
  • [53]Armijos RX, Weigel MM, Izurieta R, Racines J, Zurita C, Herrera W, Vega M: The epidemiology of cutaneous leishmaniasis in subtropical Ecuador. Trop Med Int Health 1997, 2:140-152.
  • [54]Klungsoyr P, Courtright P, Hendrikson TH: Hydatid disease in the Hamar of Ethiopia: a public health problem for women. Trans R Soc Trop Med Hyg 1993, 87:254-255.
  • [55]Sharma PP, Kumar A, Singh P: A study of gender differentials in the prevalence of tuberculosis based on NFHS-2 and NFHS-3 data. Indian J Community Med 2010, 35:230-237.
  文献评价指标  
  下载次数:32次 浏览次数:11次